Tiny genetic variation can predict outcome of ovarian cancer treatment
A tiny genetic variation predicts chances of survival and response to treatment for patients with ovarian cancer, a new study has shown
News Section | ovarian cancer
Potential breakthrough in treating late-stage ovarian cancer
University of Guelph researchers have discovered a peptide that shrinks advanced tumours and improves survival rates for ovarian cancer
Ovarian cancer feeds on fat cells in abdomen
A research team based at the University of Chicago has found that large pad of fat cells that extends from the stomach and covers the intestines provides nutrients that promote
Contraceptive pill nearly halves women’s ovarian cancer risk
Women who take the contraceptive pill for ten years almost halve their risk of being diagnosed with ovarian cancer, according to a new study
IVF doubles women’s risk of ovarian cancer 15 years later
Women who are going for fertility treatments to have babies are likely to double their chances of getting ovarian cancer, according to a new study
1st recurrent gene fusion in ovarian cancer identified
Researchers at the Stanford University School of Medicine have for the first time identified a recurrent gene fusion in ovarian cancer
New ‘Trojan Horse’ strategy to fight ovarian cancer developed
British scientists have successfully delivered a common chemotherapy drug to cancer cells inside tiny microparticles
Related News Stories
- New drug may fight ovarian cancer
- Promising new strategy for cancer therapy
- New discovery may help in the fight against ovarian cancer
- New experimental drug slows down growth of ovarian cancer
- Gene makes ovarian cancer resistant to chemotherapy
- Breast cancer drug may offer hope for treating ovarian cancer
- Engineered human T cells hit “Achilles’ Heel” of ovarian cancer cells
- Biomarker that could help spot early signs of ovarian cancer discovered